These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22299601)

  • 21. Immune interventions of human diseases through toll-like receptors.
    Coban C; Ishii KJ; Akira S
    Adv Exp Med Biol; 2009; 655():63-80. PubMed ID: 20047036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toll-like receptor signaling in parasitic infections.
    Ashour DS
    Expert Rev Clin Immunol; 2015 Jun; 11(6):771-80. PubMed ID: 25896399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical application of the anti-microbial chemical triclosan induces immunomodulatory responses through the S100A8/A9-TLR4 pathway.
    Marshall NB; Lukomska E; Nayak AP; Long CM; Hettick JM; Anderson SE
    J Immunotoxicol; 2017 Dec; 14(1):50-59. PubMed ID: 28121465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The changes in the T helper 1 (Th1) and T helper 2 (Th2) cytokine balance during HIV-1 infection are indicative of an allergic response to viral proteins that may be reversed by Th2 cytokine inhibitors and immune response modifiers--a review and hypothesis.
    Becker Y
    Virus Genes; 2004 Jan; 28(1):5-18. PubMed ID: 14739648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic helminth infections induce immunomodulation: consequences and mechanisms.
    van Riet E; Hartgers FC; Yazdanbakhsh M
    Immunobiology; 2007; 212(6):475-90. PubMed ID: 17544832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toll like receptors: a new hope on the horizon to treat multiple sclerosis.
    Gooshe M; Aleyasin AR; Abdolghaffari AH; Rezaei N
    Expert Rev Clin Immunol; 2014 Oct; 10(10):1277-9. PubMed ID: 25161080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and toll-like receptors.
    Meiler F; Klunker S; Zimmermann M; Akdis CA; Akdis M
    Allergy; 2008 Nov; 63(11):1455-63. PubMed ID: 18925882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early infections and later allergic diseases.
    Blanco Quirós A; Arranz Sanz E
    Allergol Immunopathol (Madr); 2009; 37(6):279-80. PubMed ID: 19945207
    [No Abstract]   [Full Text] [Related]  

  • 29. Dendritic cells in the circulation of women with preeclampsia demonstrate a pro-inflammatory bias secondary to dysregulation of TLR receptors.
    Panda B; Panda A; Ueda I; Abrahams VM; Norwitz ER; Stanic AK; Young BC; Ecker JL; Altfeld M; Shaw AC; Rueda BR
    J Reprod Immunol; 2012 Jun; 94(2):210-5. PubMed ID: 22440523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A balance between tissue-destructive and tissue-protective immunities: a role of toll-like receptors in regulation of adaptive immunity.
    Seledtsov VI; Seledtsova GV
    Immunobiology; 2012 Apr; 217(4):430-5. PubMed ID: 22099351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of the human immune system via toll-like receptors by the oncolytic parvovirus H-1.
    Sieben M; Schäfer P; Dinsart C; Galle PR; Moehler M
    Int J Cancer; 2013 Jun; 132(11):2548-56. PubMed ID: 23151948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ontogeny of Toll-like receptor mediated cytokine responses of human blood mononuclear cells.
    Corbett NP; Blimkie D; Ho KC; Cai B; Sutherland DP; Kallos A; Crabtree J; Rein-Weston A; Lavoie PM; Turvey SE; Hawkins NR; Self SG; Wilson CB; Hajjar AM; Fortuno ES; Kollmann TR
    PLoS One; 2010 Nov; 5(11):e15041. PubMed ID: 21152080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toll-like receptor agonists in cancer therapy.
    Adams S
    Immunotherapy; 2009 Nov; 1(6):949-64. PubMed ID: 20563267
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Pang W; Jiang Y; Li A; Zhang J; Chen M; Hu L; Li Z; Wang D
    Front Immunol; 2021; 12():620943. PubMed ID: 33815374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on toll-like receptor ligands and allergy: implications for immunotherapy.
    Horner AA
    Curr Allergy Asthma Rep; 2006 Sep; 6(5):395-401. PubMed ID: 16899201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Innate immunity.
    Turvey SE; Broide DH
    J Allergy Clin Immunol; 2010 Feb; 125(2 Suppl 2):S24-32. PubMed ID: 19932920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity.
    Kawai T; Akira S
    Immunity; 2011 May; 34(5):637-50. PubMed ID: 21616434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-33 and IL-33 receptors in host defense and diseases.
    Oboki K; Ohno T; Kajiwara N; Saito H; Nakae S
    Allergol Int; 2010 Jun; 59(2):143-60. PubMed ID: 20414050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotype and function of neonatal DC.
    Willems F; Vollstedt S; Suter M
    Eur J Immunol; 2009 Jan; 39(1):26-35. PubMed ID: 19137537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toll-Like Receptors and Tissue Remodeling: The Pro/Cons Recent Findings.
    Micera A; Balzamino BO; Di Zazzo A; Biamonte F; Sica G; Bonini S
    J Cell Physiol; 2016 Mar; 231(3):531-44. PubMed ID: 26248215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.